Carlisle Cos. Inc. (CSL)

123.65
NYSE : Producer Manufacturing
Prev Close 123.65
Day Low/High 0.00 / 0.00
52 Wk Low/High 92.09 / 127.06
Avg Volume 417.00K
Exchange NYSE
Shares Outstanding 59.74M
Market Cap 7.37B
EPS 5.80
P/E Ratio 20.07
Div & Yield 1.60 (1.19%)

Latest News

CSL Behring Hosts Symposium On Managing CIDP With Immunoglobulin, Supports 14 Scientific Posters And Two Oral Presentations At The 2018 Peripheral Nerve Society Annual Meeting

CSL Behring Hosts Symposium On Managing CIDP With Immunoglobulin, Supports 14 Scientific Posters And Two Oral Presentations At The 2018 Peripheral Nerve Society Annual Meeting

- Presentations include new analysis from the PATH trial, the largest clinical trial in CIDP

Gabelli & Company's Aerospace & Defense Conference

Gabelli & Company's Aerospace & Defense Conference

Gabelli & Company will host the 24 th Annual Aerospace & Defense Conference on Thursday, September 13th, 2018 in New York City.

Carlisle Companies To Announce Second Quarter 2018 Results On July 24, 2018

Carlisle Companies To Announce Second Quarter 2018 Results On July 24, 2018

Carlisle Companies Incorporated (NYSE:CSL) will release first quarter 2018 results on Tuesday, July 24, 2018 after the market closes.

A New Generation Of Coagulation Specialists Is Advancing Research With Support From CSL Behring Global Grant

A New Generation Of Coagulation Specialists Is Advancing Research With Support From CSL Behring Global Grant

Named after coagulation therapy pioneer Prof. Norbert Heimburger, the grant has been awarded this year to researchers from France, Netherlands and the United States.

Carlisle Companies Larger Than S&P 500 Component Tripadvisor

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Carlisle Companies Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Tripadvisor Inc , according to The Online Investor.

IDELVION® Newly Approved 3500 IU Vial To Provide Convenience To Patients Using Larger Volumes

- IDELVION 14-day dosing option for some patients, combined with the larger vial size, will improve convenience with fewer vials and less infusions

Carlisle Companies Announces Director And Officer Changes

Carlisle Companies Announces Director And Officer Changes

On May 2, 2018, the Carlisle Companies Incorporated (NYSE:CSL) held its 2018 Annual Meeting of Shareholders.

Carlisle Companies Declares Regular Quarterly Dividend

Carlisle Companies Declares Regular Quarterly Dividend

The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.

Patient Advocacy Groups Focus On Key Issues Affecting Patients

Five patient advocacy organizations are awarded LEAD Grants to support their advocacy initiatives in 2018.

Carlisle Companies Reports Record First Quarter 2018 Revenues

Carlisle Companies Reports Record First Quarter 2018 Revenues

Carlisle Companies Incorporated (NYSE:CSL) reported record revenues of $984.7 million for the first quarter of 2018, a 27.

CSL Behring, Leader In Rare Diseases, Showcases Innovations In Neuromuscular Medicine (NMM) At The 2018 American Academy Of Neurology Annual Meeting

- CSL Behring will host an industry therapeutic update highlighting findings from the PATH trial, the largest clinical trial in CIDP, and present key poster presentations featuring advances in the field of NMM

The Lancet Publishes Results Demonstrating Adjuvanted Quadrivalent Influenza Vaccine Provides Significantly Greater Efficacy In Children 6 Through 23 Months

- Study demonstrates that adjuvanted quadrivalent influenza vaccine provides 31% greater relative efficacy in preventing influenza in children 6 through 23 months compared to conventional influenza vaccine.

Carlisle Companies Incorporated To Announce First Quarter 2018 Results On April 24, 2018

Carlisle Companies Incorporated To Announce First Quarter 2018 Results On April 24, 2018

Carlisle Companies Incorporated (NYSE:CSL) will release first quarter 2018 results on Tuesday, April 24, 2018 after the market closes.

Carlisle Companies Incorporated Completes Sale Of Carlisle FoodService Products

Carlisle Companies Incorporated Completes Sale Of Carlisle FoodService Products

Carlisle Companies Incorporated (NYSE:CSL) announced today that it has completed the sale of Carlisle FoodService Products to The Jordan Company of New York, NY, for cash at an enterprise value of $750 million.

Forbes Magazine Names CSL Limited Among Top 50 Employers In The World

Forbes Magazine Names CSL Limited Among Top 50 Employers In The World

Global biotech leader rated at no. 42 for Patient Focus, Innovation, and Sustainable Growth

FDA Approves Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) For The Treatment Of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

FDA Approves Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) For The Treatment Of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

First and only subcutaneous immunoglobulin (SCIg) approved for the treatment of CIDP based on the largest controlled clinical study in CIDP

CSL Behring Receives Patient Impact Award For Subcutaneous Prophylactic Treatment To Prevent Hereditary Angioedema Attacks

CSL Behring Receives Patient Impact Award For Subcutaneous Prophylactic Treatment To Prevent Hereditary Angioedema Attacks

Life Sciences Pennsylvania recognized CSL Behring's commitment to patients for its novel subcutaneous C1 esterase inhibitor, HAEGARDA®, to prevent swelling caused by the rare genetic disorder

CSL CEO Paul Perreault Calls On Industry To Improve Patients' Access To Medicines

CSL CEO Paul Perreault Calls On Industry To Improve Patients' Access To Medicines

- Industry's role in ensuring access to medicine is an imperative, not an afterthought

Carlisle Companies Reports Record Full Year And Fourth Quarter Net Sales

Carlisle Companies Reports Record Full Year And Fourth Quarter Net Sales

Carlisle Companies Incorporated (NYSE:CSL) reported record fourth quarter 2017 net sales of $1,071.

What's Behind the Hound of Hades' Stock Market Rampage

What's Behind the Hound of Hades' Stock Market Rampage

The free market is going to take back control of interest rates.

Carlisle Companies Incorporated Authorizes Repurchase Of An Additional 5 Million Shares

Carlisle Companies Incorporated Authorizes Repurchase Of An Additional 5 Million Shares

The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) today announced a new share repurchase program that authorizes management to buy back up to an additional 5 million shares of the company's common stock...

Carlisle Companies Incorporated Declares Regular Quarterly Dividend

Carlisle Companies Incorporated Declares Regular Quarterly Dividend

The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.

Carlisle Companies Incorporated To Sell Carlisle FoodService Products

Carlisle Companies Incorporated To Sell Carlisle FoodService Products

Carlisle Companies Incorporated (NYSE:CSL) today announced the signing of a definitive agreement to sell Carlisle FoodService Products (CFS) to The Jordan Company of New York, NY, for $750 million in cash, subject to...

Carlisle Companies Incorporated To Announce 4th Quarter Results On February 8, 2018

Carlisle Companies Incorporated To Announce 4th Quarter Results On February 8, 2018

Carlisle Companies Incorporated (NYSE:CSL) will release fourth quarter 2017 results on Thursday, February 8, 2018 after the market closes.

Carlisle Companies Incorporated Elects Jesse Singh To Board Of Directors

Carlisle Companies Incorporated Elects Jesse Singh To Board Of Directors

Carlisle Companies Incorporated (NYSE: CSL) announced today that Jesse Singh, Chief Executive Officer of CPG International, has been elected to its Board of Directors, effective immediately.

TheStreet Quant Rating: B (Buy)